BIOPHYTIS (ALBPS.PA) Stock Income Statement
Europe - Euronext Paris - EPA:ALBPS - FR001400OLP5 - Common Stock
0.071 EUR
+0 (+1.43%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 1.00K | 10.00K | N/A | 0.00 | 1.00K | |||
| Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 8.17M | 8.50M | 14.00M | 23.27M | 26.82M | |||
| Research and Development | 3.21M | 4.47M | 10.41M | 19.45M | 24.00M | |||
| Selling, General, and Administrative Expenses | 2.03M | 2.29M | 1.57M | 4.11M | 3.11M | |||
| Operating Income | -8.17M | -8.50M | -14.00M | -23.27M | -26.82M | |||
| Interest Income/Expense | -238.00K | -1.89M | -2.15M | 23.00K | -2.38M | |||
| Other Income/Expense | 378.00K | 0.00 | -540.00K | -967.00K | -1.97M | |||
| Income Before Taxes | -8.03M | -10.00M | -17.00M | -24.22M | -31.16M | |||
| Income Tax | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Net Income | -8.03M | -10.00M | -17.00M | -24.22M | -31.16M | |||
| EBITDA | -7.63M | -8.02M | -13.20M | -22.79M | -26.50M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.84 | -1.92 | -12.49 | -55.40 | -105.39 | |||
| Statistics | ||||||||
All data in EUR